Investment and market analysis, commentary, outlook, and practice resources for financial industry professionals.
The Latest

Biotech and the Race for a Vaccine

byCarmen Tang
March 13, 2020
1 minute read
Total
0
Shares
0
0
0
0

by Carmen Tang, AGF Management Ltd.

For Print Only Logo

Insights and Market Perspectives

Author:Ā Carmen Tang

March 13, 2020

Carmen Tang, AGF equity analyst, discusses the efforts now ongoing across the biotechnology sector to help combat the COVID-19 virus.

About AGF Management Limited

Founded in 1957, AGF Management Limited (AGF) is an independent and globally diverse asset management firm. AGF brings a disciplined approach to delivering excellence in investment management through its fundamental, quantitative, alternative and high-net-worth businesses focused on providing an exceptional client experience. AGFā€™s suite of investment solutions extends globally to a wide range of clients, from financial advisors and individual investors to institutional investors including pension plans, corporate plans, sovereign wealth funds and endowments and foundations.

For further information, please visit AGF.com.

Ā© 2020 AGF Management Limited. All rights reserved.

This post was first published at the AGF Perspectives Blog.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Author
Carmen Tang
Previous Article

Panic is Not an Investment Strategy

byCharles Schwab and Company
March 13, 2020
Next Article

What could short-term volatility mean for long-term investors?

byInvesco Canada
March 14, 2020
Related Posts
Read More

Women & Alts: A Global Perspective with Barbara Stewart

In this episode of Insight is Capital, Pierre Daillie welcomes Barbara Stewart, CFA, a renowned global researcher, author,…
byInsight is Capitalā„¢ Podcast
Subscribe to AdvisorAnalyst.com notifications
Watch. Listen. Read. Raise your average.